This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Chang Gung University, National Tsing Hua University, Kaohsiung Chang Gung Memorial Hospital. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 185 
2 out of 1,308 
1 out of 12 Years Active: 2017-2021
Title: Shiuann-Sheng Lee: Innovator in Microfluidic Systems
Introduction
Shiuann-Sheng Lee is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of microfluidics, particularly in the development of systems for personalized drug screening and antibiotic susceptibility testing. With a total of 4 patents to his name, Lee's work is at the forefront of medical technology innovation.
Latest Patents
Lee's latest patents include an "Automatic Microfluidic System for Rapid Personalized Drug Screening" and a "Testing Method for Personalized Antibiotic Susceptibility." The first patent describes a microfluidic chip that incorporates a fluid storage unit, a fluid driving unit, a reaction unit, and multiple valve units. This system utilizes two mixing pumps, each consisting of pneumatic micro-pumps and a mixing chamber, to facilitate rapid drug screening. The second patent focuses on an automatic microfluidic system designed for antibiotic susceptibility testing, featuring a microfluidic chip that stores bacterial suspensions, broths, and antibiotic solutions. This innovative design allows for the selective and quantitative transport of solutions to create mixing solutions for testing.
Career Highlights
Throughout his career, Shiuann-Sheng Lee has worked with esteemed institutions such as Tsinghua University and Chang Gung University. His research and development efforts have significantly advanced the capabilities of microfluidic technologies in medical applications.
Collaborations
Lee has collaborated with notable colleagues, including Gwo-Bin Lee and Wen-Bin Lee, contributing to the advancement of microfluidic systems and their applications in healthcare.
Conclusion
Shiuann-Sheng Lee's innovative work in microfluidic systems exemplifies the potential of technology to transform personalized medicine. His contributions continue to pave the way for advancements in drug screening and antibiotic testing, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile